Johnathan M. Lancaster

Johnathan M. Lancaster, MD, PhD, joined Regeneron in 2019 as a Vice President and now serves as SVP and Head of Global Medical Affairs. Prior to joining Regeneron, Dr. Lancaster served as Chief Medical Officer at Myriad Genetics, Inc., following more than a decade in academics at Moffitt Comprehensive Cancer Center in Tampa as a gynecologic oncologist, molecular genetics researcher, and ultimately President of the Moffitt Medical Group Corporation. Dr. Lancaster received his BSc in Pharmacology and his MD and PhD from the University of Wales in the UK. He received post graduate clinical training in OBGYN and Gynecologic Oncology at the University of Cambridge and Duke University Medical Center.